Analyst Expectations for Gossamer Bio's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. The average price target is $5.4, implying an upside from the current price of $1.18. This represents a 22.86% decrease from the previous average price target of $7.00.
August 11, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts predict an upside for Gossamer Bio with an average price target of $5.4, a decrease from the previous target.
The analysts' average price target for Gossamer Bio indicates a potential upside from the current price, which could lead to a positive impact on the stock price. However, the decrease in the price target compared to the previous one might indicate less optimism about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100